Progress in Understanding Liver Cancer Environment and Immune-Based Treatments

Hepatocellular carcinoma (HCC) presents significant challenges due to an immunosuppressive tumor microenvironment that may hinder therapy effectiveness.

• The tumor microenvironment in HCC is characterized by components such as tumor-associated macrophages, regulatory T cells, and myeloid-derived suppressor cells that contribute to immune escape.
• Immunotherapy, particularly immune checkpoint inhibitors, has improved treatment options but often provides limited benefit as a standalone therapy.
• Combination strategies targeting multiple immune checkpoints and integrating anti-angiogenic agents could enhance the efficacy of immunotherapy.
• The review highlights the interaction between the tumor microenvironment and immune responses, suggesting that combination regimens may help to overcome immune resistance.
• Challenges remain, including therapeutic resistance and adverse immune-related effects, which need to be addressed for improved patient outcomes.

Simplified